These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Anti-diabetic treatment, insulin resistance and cardiovascular disease in patients with type 2 diabetes].
    Author: Hemmingsen B, Lund SS, Vaag A.
    Journal: Ugeskr Laeger; 2009 May 04; 171(19):1598-602. PubMed ID: 19419642.
    Abstract:
    This article reviews the current evidence of effects on cardiovascular disease (CVD) of anti-diabetic treatment which exert their effect by increasing the insulin sensitivity in patients with type 2 diabetes (T2D). In overweight T2D patients, it has been demonstrated that metformin reduces the CVD risk. The effect of glitazones on CVD is uncertain. There is insufficient evidence to support a protective effect on CVD of lowering blood-glucose per se. In contrast, lowering blood glucose appears to decrease the risk of microvascular complications.
    [Abstract] [Full Text] [Related] [New Search]